Tau Timing: New Findings on Disease Progression, Clearance
The spotlight seems to be shifting to a greater interest in tau as a therapeutic target...
6381 RESULTS
Sort By:
The spotlight seems to be shifting to a greater interest in tau as a therapeutic target...
As amyloid precursor protein (APP) gets sliced and diced, the fragments coming off the β-secretase tend to steal the show...
Recent clinical trial results present a mixed bag of good and bad news...
Having nightmares is bad enough, but some people actually act out their dreams while asleep, a syndrome known as rapid eye movement (REM) sleep behavior disorder (RBD)...
The Alzheimer’s Breakthrough Ride started on 17 July 2010 in San Francisco and culminated yesterday, World Alzheimer’s Day, in Washington, DC...
Every protein-coding RNA needs a termination codon or translation will run right on through the poly-adenine tail, producing a run of superfluous lysines...
The autumnal equinox, when the whole world gets equal time in the sunlight, might be an appropriate time to take a global view of Alzheimer disease...
Are you curious about trying iPS cell lines to model the disease you care about? Intrigued but nebulous on where the field is at? Ready to grow an iPS line but not sure where to turn? Read Madolyn Rogers's four-part series to learn all about who does
IPS cells have created excitement among researchers who see them as more available, easier to make, and less ethically conflicted than embryonic stem cells...
What makes some areas of the brain more vulnerable to Aβ? A pair of related papers offer a clue...
Amyloid precursor protein (APP) exports iron from neurons...
One of the three iPSC consortia funded by the National Institute of Neurological Disorders and Stroke (NINDS) is creating lines for ALS...
New data may inspire some AD researchers to consider expanding their postmortem analyses to include tissue from a curious source—the liver...
While scientists are steaming ahead on establishing iPSC lines for research into PD and ALS, they have been more reluctant to embrace the technology for AD...
Since the discovery, in 2006, that adult cells could be reprogrammed to a pluripotent state, scientists have been excited by their potential...